APELLIS PHARMACEUTICALS INC (APLS)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for APLS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| APLS | 63 | ["CEO of Headwaters Biotech Advisors (2020 \u2013 present)", "President and Chief Executive Officer of Momenta Pharmaceuticals (2006 \u2013 2020)", "President of Chiron Biopharmaceuticals (2001 \u2013 2006)", "Senior member of The Boston Consulting Group\u2019s health care practice", "Expertise and extensive leadership experience in pharmaceutical industry", "Expertise in drug development, manufacturing, and the technical issues facing growing biopharmaceutical companies"] | ["Audit"] | 2025 |
Biography sourced from the proxy statement filing.
Age: 63 Independent Director since 2025 Committees: Audit Experience CEO of Headwaters Biotech Advisors (2020 present) President and Chief Executive Officer of Momenta Pharmaceuticals (2006 2020) President of Chiron Biopharmaceuticals (2001 2006) Senior member of The Boston Consulting Group s health care practice Qualifications Expertise and extensive leadership experience in pharmaceutical industry Expertise in drug development, manufacturing, and the technical issues facing growing biopharmaceutical companies Education M.B.A., Wharton School of the University of Pennsylvania M.S., Cornell University B.S., Cornell University Other Boards Amicus Therapeutics, Inc. (2016 present) Avanir Pharmaceuticals, Inc (2005 2016) Momenta Pharmaceuticals, Inc. (2006 2020)